Diest, Belgium

Jean Francois Alexandre Lucas

This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean Francois Alexandre Lucas. Retrieved from https://idiyas.com/inventor/jean-francois-alexandre-lucas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jean Francois Alexandre Lucas: Innovator in Pharmaceutical Chemistry

Introduction

Jean Francois Alexandre Lucas is a notable inventor based in Diest, Belgium. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds aimed at treating various disorders.

Latest Patents

Lucas holds a patent for "Salts of 3-(3-amino-2-(R)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one." This invention is directed towards salts of the compound, pharmaceutical compositions containing them, and their application in treating disorders modulated by NOP, such as depression, anxiety, and alcohol abuse. The patent also covers processes for preparing the compound and its corresponding salts.

Career Highlights

Lucas is associated with Janssen Pharmaceutica NV, a leading pharmaceutical company known for its innovative research and development. His work has contributed to advancements in therapeutic solutions that address critical health issues.

Collaborations

Lucas has collaborated with esteemed colleagues, including Steven Mehrman and Armin Roessler, to further enhance the impact of his research and inventions.

Conclusion

Jean Francois Alexandre Lucas exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to influence the development of effective treatments for various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…